New MSF report shows slow progress in adopting and implementing key TB prevention, testing and treatment policies and practices.

WHO/Europe releases a blueprint for a people-centred model of TB care that shifts care closer to people and communities.

A new document provides a strategic overview of key implementation considerations for diagnostic integration using testing devices for TB, HIV and viral hepatitis.

Communities Delegation targeted call for membership.
Application deadline: 12 July 2017

Like the established World Health Organization (WHO) Essential Medicines List, the Essential Diagnostics List is intended to provide evidence-based guidance to countries to create their own national lists of essential diagnostic tests and tools.

The World Health Organization is inviting feedback via an online consultation on the Zero Draft of the Declaration proposed for the Global Ministerial Conference on TB to be held in Moscow on 16-17 November 2017.

WHO updates Essential Medicines List with new advice on use of antibiotics and adds medicines for TB.

The report emphasizes that actions and investments by countries are falling too short; renewed action and an acceleration of efforts are needed to reach the targets set within the End TB Strategy and the Sustainable Development Goals.

The full disclosure of President Trump's FY18 budget reaffirms the current administration's intention of scaling-back critical progress in programs and research made in the fight against HIV/AIDS, TB and HCV.

The toolkit is designed to facilitate community participation in the development and review of clinical trials protocols.